Amerita,
Inc. is a privately held Specialty Infusion company
focused on providing complex pharmaceutical products
and clinical services to patients outside of the hospital.
This market is expanding rapidly and is driven by increasing
healthcare costs that are moving patients into the
most cost effective delivery settings, a growing bio-pharmaceutical
pipeline of infuseable and injectable medications,
an aging population and the recent addition of a Medicare
benefit for these products and services.
What is Specialty Infusion?
Specialty
infusion therapy services primarily involve the intravenous
administration of medications that treat a wide range
of acute and chronic health conditions such as infections,
auto-immune illnesses, cancer, pain, multiple sclerosis,
hemophilia and nutritional deficiencies. To ensure
quality, medications are compounded in a sterile clean
room environment, dispensed under the supervision of
a local registered pharmacist and delivered directly
to the home of the patient. Amerita then coordinates
visits by a registered nurse, the frequency of which
is dependent on the treatment type and the patient
or caregiver's ability to safely administer the medication.
These drugs do not typically fit into the retail drug
distribution model as they are high cost, may need
special handling and require extensive patient training
and/or administration by a clinician. Patients are
generally referred by physicians, hospital discharge
planners, home-health agencies and managed care organizations.
Our Strategy
We believe that specialty infusion is a local business. We
work closely with our referral sources to build the
trust needed to service their complex patient’s
needs outside of the hospital. This trust can
not be earned from a centralized or remote location. Our
local model assures the responsiveness, quality and
personal touch that our customers expect. Our growth
plan calls for the purchase of small to medium sized
home infusion companies throughout the southern United
States that have excellent clinical and service reputations. After
we purchase a company we invest in a growth plan that
expands the geographic reach of the company as well
as builds new clinical expertise in selected therapies. We
will also open new branches in selective markets that
will increase our geographic coverage and our ability
to service more patients across the country. As
we continue to grow we will take advantage of the purchasing
and administrative efficiencies of a large company
while keeping the entrepreneurial culture and local
focus of a small company. We believe this unique
combination will allow us to effectively compete at
the local, regional and national levels.
Our Investment Partners
We have a knowledgeable and experienced equity partner
in Ferrer Freeman and
Company. FFC manages
over $900 million and is exclusively focused on the
health care industry. The firm has invested
extensively across the healthcare services sector,
including being the largest investor in Amerigroup,
a Virginia Beach-based Medicaid managed care provider. FFC
as also invested in hospitals (Ardent Health Systems
and Ernest Health), surgery centers (United Surgical
and National Surgical) and other alternate site providers
(VistaCare, Aerocare, Physicians Dialysis). We
believe this broad investment experience establishes
a deep understanding of the issues the company faces
in today’s marketplace and provides valuable
feedback for management.
|
